相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials
Hedde D. Biesma et al.
GASTRIC CANCER (2022)
Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in patients (pts) with localized microsatellite instability-high (MSI)/mismatch repair deficient (dMMR) oeso-gastric adenocarcinoma (OGA): The GERCOR NEONIPIGA phase II study
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer
Meike Kohlruss et al.
BRITISH JOURNAL OF CANCER (2021)
Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK
S-E. Al-Batran et al.
ANNALS OF ONCOLOGY (2021)
Prognostic and predictive value of mismatch repair deficiency in gastric and gastroesophageal junction adenocarcinoma patients receiving neoadjuvant or adjuvant chemotherapy
Ziyu Li et al.
JOURNAL OF SURGICAL ONCOLOGY (2021)
Evaluation of the prognostic impact of pathologic response to preoperative chemotherapy using Mandard's Tumor Regression Grade (TRG) in gastric adenocarcinoma
Simon Derieux et al.
DIGESTIVE AND LIVER DISEASE (2020)
Is Adjuvant Chemotherapy Necessary for Patients with Deficient Mismatch Repair Gastric Cancer?-Autophagy Inhibition Matches the Mismatched
Chun-Yi Tsai et al.
ONCOLOGIST (2020)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer
Filippo Pietrantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
523OFOxTROT: An international randomised controlled trial in 1053 patients evaluating neoadjuvant chemotherapy (NAC) for colon cancer. On behalf of the FOxTROT Collaborative Group
D Morton
ANNALS OF ONCOLOGY (2019)
Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status
Romain Cohen et al.
JAMA ONCOLOGY (2019)
Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)
Aziz Zaanan et al.
DIGESTIVE AND LIVER DISEASE (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Charles S. Fuchs et al.
JAMA ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer
K. Polom et al.
BRITISH JOURNAL OF SURGERY (2018)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Mismatch Repair Deficiency, Microsatellite Instability, and Survival An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial
Elizabeth C. Smyth et al.
JAMA ONCOLOGY (2017)
Tumor response evaluation after neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: a prospective, multi-center cohort study
Pietro Achilli et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies
G. Tomasello et al.
EJSO (2017)
Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China
Yuelu Zhu et al.
BMC GASTROENTEROLOGY (2017)
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer
Daniele Marrelli et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. C. Smyth et al.
ANNALS OF ONCOLOGY (2016)
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
Elizabeth C. Smyth et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Tumor regression grade in gastric cancer: Predictors and impact on outcome
Aaron U. Blackham et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET ONCOLOGY (2016)
Usefulness of Immunohistochemistry for Microsatellite Instability Screening in Gastric Cancer
Yoon Sung Bae et al.
GUT AND LIVER (2015)
The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses
Soo Young Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
E. Bajetta et al.
ANNALS OF ONCOLOGY (2014)
Is Microsatellite Instability a Prognostic Marker in Gastric Cancer?: A Systematic Review With Meta-Analysis
Yoon Young Choi et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Posttherapy Nodal Status, Not Graded Histologic Response, Predicts Survival after Neoadjuvant Chemotherapy for Advanced Gastric Cancer
Kazumasa Fujitani et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Adenocarcinomas of the Esophagogastric Junction Are More Likely to Respond to Preoperative Chemotherapy than Distal Gastric Cancer
Daniel Reim et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
Jeeyun Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas A Summary of 480 Cases
Karen Becker et al.
ANNALS OF SURGERY (2011)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
Daniel J. Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
John C. Mansour et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy
K Becker et al.
CANCER (2003)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
